对肠道微生物群和乐伏多巴代谢研究的综述
Zhe Zhong1, Min Ye2, Fuling Yan1
1Department of Neurology, Affiliated Zhongda Hospital, School of Medicine, Research Institution of Neuropsychiatry, Southeast University, Nanjing, China.
Frontiers in neurology
|June 19, 2023
概括
肠道微生物通过影响勒沃多巴 (L-多巴) 吸收,影响帕金森病 (PD) 治疗. 本综述探讨了PD的微生物机制和干预策略.
科学领域:
- 神经科学是一个神经科学.
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病.
- 利沃多巴 (L-dopa) 是主要的治疗方法,但由于"磨损"和运动障碍等并发症,疗效随着时间的推移而减弱.
- 人们越来越多地认识到肠道微生物群在PD病变发生中的作用,但其对L-dopa代谢的影响仍然不清楚.
研究的目的:
- 调查肠道微生物群影响多巴 (L-dopa) 在帕金森病中吸收的机制.
- 审查目前用于PD治疗的肠道微生物群向干预策略.
主要方法:
- 对PD患者肠道微生物群组成研究的文献综述.
- 在L-dopa代谢中涉及特定细菌 (例如,Helicobacter pylori*,Enterobacter faecalis*,Clostridium sporogenes*) 的拟议机制的分析.
- 对PD微生物群调节疗法的当前研究综合.
主要成果:
- 某些肠道细菌可能会直接影响L-dopa的吸收和疗效.
- 在帕金森病患者中,肠道微生物群的组成可能会发生变化.
- 新兴的战略重点是调节肠道微生物组,以改善PD治疗结果.
结论:
- 肠道微生物群显著影响莱沃多巴 (L-dopa) 代谢和帕金森病治疗的有效性.
- 了解这些微生物相互作用为新的治疗方法提供了潜力.
- 准肠道微生物群是一个有希望的途径,以提高PD管理.
相关概念视频
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
417
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
417
01:24Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
164
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
164
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
317
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
317
01:20Gastrointestinal Motility Disorders
461
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
461
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
593
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
593